Additional European Equity News - 30th October 2026

Airtel Africa (AAF LN) - H1 2026 (USD): Revenue 3.82bln (prev. 2.98bln Y/Y), Operating Profit 1.29bln (prev. 0.96bln Y/Y), Profit after Tax 452mln (prev. 376mln Y/Y). Declares an interim dividend of 0.031/shr, +9.2% Y/Y. CEO: “Positioned to deliver sustainable growth at scale and long-term value for shareholders.” (Airtel Africa)

AstraZeneca (AZN LN) - Q3 2026 (USD): Revenue 16.2bln (exp. 16bln), Adj. EPS 2.79 (exp. 2.59). Confirms FY26 guidance. CEO: "We have had approvals for four new medicines and reported 12 positive Phase III programme readouts with a collective peak year revenue potential well in excess of ten billion dollars. Our rich series of upcoming readouts in 2027 has a potential of more than twenty billion dollars. With multiple potential blockbuster assets in late-stage development and transformative technologies scaling rapidly, we are on track to deliver our 2030 ambition and to sustain growth through the next decade.”

BP (BP/ LN) - Q3 2026 (USD): Revenue 69.9bln (exp. 66.2bln), Adj. Net Income 8.46bln (exp. 7.26bln), Operating Cash Flow 14.83bln (exp. 13.32bln), Net Debt 13.9bln (exp. 14.3bln) Guidance: Expects Q4 upstream production of 2.09-2.23mln BOEPD, reflecting continued Middle East disruptions, activity phasing at bpx energy, seasonally lower gas demand and a c. 20k boe/d impact from Gulf of America weather, partially offset by recovery from outages. FY26 upstream production now expected at 2.21-2.25mln BOEPD, reflecting Middle East disruptions, the Culzean gas field divestment and reduced Latin American equity interests. CEO: "Our intent is now to prioritize the use of excess cashflow to address our remaining Deepwater Horizon liabilities in full." (BP)

Evonik (EVK GY), BASF (BAS GY) - Evonik reportedly plans to reject BASF's improved EUR 11bln takeover offer of EUR 24/shr, deeming the proposal too low and undervaluing the speciality chemicals group, according to FT citing sources. A formal statement could follow in the coming days. (FT)

NatWest (NWG LN) - Q3 2026 (GBP): PBT 2.23bln (exp. 2.2bln), NII 3.55bln (exp. 3.6bln), Total Income 4.464bln (exp. 4.64bln), NIM 2.5% (exp. 2.51%), CET1 13.5% (exp. 13.4%). Reaffirm outlook provided in H1. (NatWest)

Puma (PUM GY) - Q3 2026 (EUR): adj. Sales 1.78bln (exp. 1.76bln), Gross Profit Margin 49.5% (prev. 45.4%); sales declined due to reset measures and weaker consumer demand. FY Guidance: narrowed EBIT range, CAPEX seen <150mln (prev. guided c. 200mln). (EQS)

Stora Enso (STERV FH) - Co.'s Board of Directors approves demerger plan to separate Bergslagets Skogar into a new listed company, and announces strategic targets and dividend policy for Bergslagets Skogar. (Stora Enso)

Tesco (TSCO LN) - Co. plans to sell its Czech and Slovakian business to Ahold Delhaize (AD NA) at an enterprise value of EUR 1.7bln. (Tesco)

Wolters Kluwer (WKL NA) - Co. announces it has signed an agreement to sell its German consumer tax business for EUR 40mln. (Wolters Kluwer)